Silo Pharma, Inc.
corporate_fare Company Profile
Silo Pharma, Inc. (NASDAQ:SILO) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 23 items for SILO at importance 7 or higher on its 1–10 market-impact scale.
Recent high-impact activity:
- Silo Pharma Acquires QwikAgents Software, Issuing 2.1M Shares for Significant Dilution
- Silo Pharma Faces Nasdaq Delisting Threat Amidst Heavy Dilution and Strategic Shift to Crypto
- Silo Pharma Authorizes $1M Share Buyback, Offsetting Recent Dilutive Stock-for-Services Payment
Financial Snapshot
Fiscal year ended December 31, 2025
Revenue
$72.1K
Net Income
-$4.23M
Diluted EPS
-$0.50
Op. Cash Flow
-$4.66M
Gross Profit
$27.81K
Operating Income
-$4.28M
Cash & Equivalents
$4.75M
Debt / Equity
0.00×
Net Margin
-58.63×
Shares Outstanding
13.32M sh
Source: 10-K · filed 2026-03-27 · accession 0001213900-26-035576
show_chartPrice Chart
Loading chart...
feed SILO - Filings & News (Page 2)
SILO
Apr 02, 2026, 4:15 PM EDT
Price at Filing:
$0.3555
Real-time Price:
$1.71
Change:
Reverse Stock Split
Market Cap:
$3.624M
SILO
Mar 27, 2026, 4:40 PM EDT
Price at Filing:
$0.357
Real-time Price:
$1.71
Change:
Reverse Stock Split
Market Cap:
$3.624M
SILO
Feb 23, 2026, 5:00 PM EST
Price at Filing:
$0.4007
Real-time Price:
$1.71
Change:
Reverse Stock Split
Market Cap:
$3.624M